Blog

  • Huntsman Launches New Range of Safer, More Sustainable ARALDITE® Epoxy Adhesives :: Huntsman Corporation (HUN)

    Huntsman Launches New Range of Safer, More Sustainable ARALDITE® Epoxy Adhesives :: Huntsman Corporation (HUN)







    THE WOODLANDS, Texas – Huntsman Advanced Materials, a division of Huntsman Corporation, has announced the launch of a newly reformulated range of ARALDITE® epoxy adhesives that are free from intentionally added BPA (Bisphenol A) and substances classified as CMR (Carcinogenic, Mutagenic, or Reprotoxic) under the EU’s CLP regulation.

    “We’re pleased to introduce our newly reformulated ARALDITE® epoxy adhesive range, developed to better serve the evolving needs of our customers. With a long-standing commitment to innovation, Huntsman focuses on delivering solutions that tackle our clients’ most complex challenges and lead the way in meeting evolving regulatory and customer demands, setting the standard for performance and reliability,” said Dr. David Hatrick, Vice President of Strategic Marketing & Innovation for Huntsman Advanced Materials.

    The initial phase of the rollout includes the launch of ARALDITE® 2014-3, ARALDITE® 2020-1, and ARALDITE® AV 138 M-2, which are now available in Europe. Additional products, including ARALDITE® 2012-1, ARALDITE® 2013-2, and ARALDITE® 2015-2, will become commercially available in the region starting October 2025.

    ARALDITE® adhesives have set the industry benchmark for reliability and performance for over 80 years, supporting a wide range of applications in transportation, marine, medical, wind energy, and industrial manufacturing. The products are widely used in the production and assembly of buses, trucks, rail vehicles, filtration systems, and more.

    As part of its broader sustainability strategy, Huntsman has introduced a new Post-Consumer Recycled (PCR) plastic cartridge, which will be incorporated into some products within the new range. This PCR-plastic cartridge helps reduce CO₂ emissions by up to 36% compared to similar cartridges made from virgin plastic materials.

    “The launch of our next-generation ARALDITE® epoxy adhesives underscores Huntsman’s commitment to delivering high-quality, sustainable solutions that protect both people and the environment,” said Alexander Weis, Operational Marketing Manager for Huntsman Advanced Materials in Europe.

    “These reformulated products are not classified and labeled as CMR, enabling the highest level of safety for workers and operators. We look forward to collaborating with our suppliers and partners to bring these advanced adhesives to market, while giving customers the same trusted ARALDITE® performance they rely on – without the need for requalification.”

    The newly reformulated ARALDITE® adhesives are available through Huntsman’s established network of distribution partners, including Bodo Möller Chemie, Samaro, Antala, Emmanuele Mascherpa, Viba, and Biesterfeld.

    The current product range will remain available until approximately the end of 2026.

    –

    About Huntsman

    Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2024 revenues of approximately $6 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. Huntsman operates more than 60 manufacturing, R&D, and operations facilities in nearly 30 countries, and employs approximately 7,000 associates within its continuing operations.

    Media Contact:
    For more information, please contact Kammy Reece, Global Communications Director for Huntsman Advanced Materials at kammy_reece@huntsman.com or +1 281 719 4006.

    Released September 17, 2025

    Continue Reading

  • Will Twenty One Pilots’ ‘Breach’ Top the Billboard 200 Next Week?

    Will Twenty One Pilots’ ‘Breach’ Top the Billboard 200 Next Week?

    The Contenders is a midweek column that looks at artists aiming for the top of the Billboard charts, and the strategies behind their efforts. This week, for the upcoming Billboard 200 dated Sept. 27, we look at the latest from alt-pop stars Twenty One Pilots and its likelihood of scoring its first No. 1 since its breakout 10 years ago.  

    Explore

    See latest videos, charts and news

    Twenty One Pilots, Breach (Fueled by Ramen): It was almost exactly a decade ago that Twenty One Pilots made the leap from cult favorites to pop stars, as the duo of Tyler Joseph and Josh Dun scored its first No. 1 album on the Billboard 200 with the blockbuster set Blurryface. The set ultimately spawned two top five hits on the Billboard Hot 100 (“Stressed Out” and “Ride”) and led to the Pilots winning best pop duo/group performance (for “Stressed”) at the 2017 Grammys, cementing it as one of the mid-2010s’ biggest breakout acts.  

    In the decade since, while Twenty One Pilots has receded from the top 40 spotlight a bit, the duo has remained a top touring act and a consistently successful albums act as well. However, the No. 1 spot has remained elusive for the Pilots since Blurryface: 2018 follow-up Trench got stuck at No. 2 behind Lady Gaga & Bradley Cooper’s A Star Is Born soundtrack, while both 2021’s Scaled & Icy and 2024’s Clancy ended up debuting and topping out at No. 3.  

    Next week, the duo should have a good chance to break that drought. On Sept. 12, Joseph and Dun released Breach, considered the final installment in the conceptual album series fans have followed from the duo since Blurryface. The set was preceded by a pair of singles, “The Contract” and “Drum Show,” both of which have reached the top 25 of Billboard’s Hot Rock & Alternative Songs chart.  

    Though the set should stream respectably — the duo’s biggest 2010s hits are among the most-streamed songs of their era, though their 2020s singles haven’t produced similar numbers — most of the album’s performance will undoubtedly come via sales. To that end, the duo and its Fueled by Ramen label are highly prepared: There are at least 15 vinyl variants available for purchase of Breach, as well as three deluxe CD boxed sets (with extensive packaging and collectible items contained within), a widely available standard CD and both standard and deluxe digital downloads, the latter also containing a bonus track and PDF booklet.  

    Excitement over the Pilots’ decade-spanning narrative’s final installment, combined with the variety of available physical editions and a relatively slow release week, could result in the duo once again aviating its way to the Billboard 200’s apex.  

    Ed Sheeran, Play (Gingerbread Man/Atlantic/Warner): Another one of the defining pop acts of the mid-’10s, Ed Sheeran was once considered a near-lock to debut atop the Billboard 200 with every new album, as he did with four consecutive new sets from 2014 to 2021. In recent years, however, his Midas touch on the charts has dulled slightly, and his last two sets — 2023’s – (Minus) and 2024’s Autumn Variations — missed the top spot, while failing to generate the long-lasting hit singles his earlier albums had easily spun off.  

    Still, Sheeran has remained a stadium-level live act, and has already reached the Hot 100 three times with the advance cuts from his recently released Play album — “Azizam,” “Sapphire” and “Old Phone” — though only “Azizam” reached the top 40, peaking at No. 28. And as Twenty One Pilots finishes its album series, Sheeran starts a new one: Play, advertised as Sheeran’s return to pop after a couple more personal, acoustic LPs, is the first in an expected sequence of albums titled after media control symbols, with Pause, Fast Forward, Rewind and Stop expected to follow.  

    Play also has a wide variety of physical media options available for fans, including at least 10 vinyl variants, four standard and two deluxe CD variants, and a deluxe edition for digital download and streaming that includes five bonus tracks. Sheeran’s sales numbers on recent releases have not been as robust as those of Twenty One Pilots, and Play has yet to produce a major breakout hit on streaming, so fans will have to show their investment in the singer-songwriter’s return to top 40 pop for him to have a major chance at debuting at No. 1.  

    KPop Demon Hunters Soundtrack (Visva/Republic): The current bar to clear for albums looking to capture the Billboard 200’s top spot is of course the soundtrack currently reigning at No. 1. KPop Demon Hunters finally captured the top spot last week after a three-month climb — helped by a digital deluxe edition and its first wide release on CD — but its numbers should come back down a bit next week, especially as the set’s many hit songs finally seem to be losing a little steam on streaming. Don’t count HUNTR/X and the Saja Boys out, though — they’ll still likely finish around the top next week, and could still be in the mix to reclaim No. 1 for a good many weeks to come.  

    Continue Reading

  • New AACR Cancer Progress Report Spotlights Notable Gains, Ongoing Challenges in Research

    New AACR Cancer Progress Report Spotlights Notable Gains, Ongoing Challenges in Research

    The American Association for Cancer Research (AACR) published the 15th edition of their Annual Cancer Progress Report, which highlighted recent advances in cancer care, ongoing challenges in the field, and called for continued financial support from the federal government.1

    Spanning 1991 to 2023, there was a 34% reduction in the overall cancer death rate, translating to over 4.5 million lives saved, according to the report.1,2 Moreover, there are now 18.6 million cancer survivors in the United States in 2025, representing 5.5% of the total population; this figure has increased from 3 million survivors in 1971, which represented 1.4% of the country’s population at that time. In 2025, an estimated 6.2 million cancer survivors are living for at least 15 years after diagnosis, and this figure is expected to grow to 10.4 million by 2040.

    “This report chronicles new scientific advances and technological innovations that are saving lives, and it also shines a light on the challenges we face from rising early onset cancers to persistent cancer disparities and outcomes,” Margaret Foti, PhD, MD, chief executive officer of the AACR, said during a presentation of the report.1 “The AACR is working very hard to confront these challenges, convening leading experts in all sectors in dedicated conferences to accelerate solutions. This report is so much more than a publication. It is both a measure of how far we have come and a signal of how far we still must go.”

    What Were the Other Highlights of the AACR 2025 Annual Cancer Progress Report?

    The report also noted that between July 1, 2024, and June 30, 2025, the FDA has approved 20 new anticancer therapeutics.1,2 Eight previously approved agents were also indicated for the treatment of new cancer types. Two new devices earned FDA approval—1 each in lung cancer and cervical cancer—along with 2 minimally invasive tests for the screening of colorectal cancer (CRC). Several artificial intelligence (AI)–based tools aimed at improving early detection and diagnosis also gained FDA approval.

    In terms of hematologic malignancies, the report noted that the mortality rates of chronic myeloid leukemia, non-Hodgkin lymphoma, and multiple myeloma have all decreased from 1991 to 2023, at respective rates of 71%, 43%, and 31%. Over the past 10 years, 29 new molecularly targeted therapeutics, including 4 antibody-drug conjugates, have received FDA approval for the treatment of patients with hematologic malignancies; 21 of these were new immunotherapeutics, including 7 CAR T-cell therapies and 8 bispecific T-cell engagers (BiTEs). Over the course of the 12 months preceding the report, the FDA approved revumenib (Revuforj), the first menin-directed therapy, for select patients with relapsed/refractory acute leukemia; denileukin diftitox-cxdl (Lymphir), a novel cytotoxic fusion protein, for patients with relapsed/refractory cutaneous T-cell lymphoma; and a new CAR T-cell therapy, obecabtagene autoleucel (Aucatzyl), in acute lymphocytic leukemia.

    The report also spotlighted the rapid progress in the development of immunotherapy approaches. From 2011 to 2015, the number of FDA-approved immune checkpoint inhibitors (ICIs) rose from 1 to 15. The numbers of FDA-approved adoptive T-cell therapies and BiTEs both rose from 0 to 9 over this time span. In 2025, there are more than 20 cancer types for which an ICI is approved, rising dramatically from just 1 tumor type in 2011. More than half (56.5%) of patients with cancer in the United States are eligible for treatment with an ICI in 2025 compared with 1.5% in 2011.

    “The use of ICIs has expanded at an unprecedented pace,” Lillian L. Siu, MD, FAACR, FRCPC, the Steering Committee Chair and president of the AACR, noted during the presentation. “When the first edition of [the AACR Annual Cancer Progress Report] was released in 2011, only one ICI had been approved, and that was only for metastatic melanoma. As of June 30, 2025, there were 15 ICIs approved by the FDA, including 2 new ones reported in this year’s cancer progress report. These drugs can now be used to treat 22 different cancer types, as well as any type of solid tumors characterized by specific biomarkers.”

    Siu is also a professor at the University of Toronto Medical Oncologist, as well as the director of the Princess Margaret Cancer Centre and the Phase I Clinical Trials Program BMO Chair in Precision Cancer Genomics Princess, at Margaret Cancer Centre, University Health Network, both in Toronto, Canada.

    The proportion of total cancer deaths averted due to screening and removal of precancerous lesions from 1975 to 2020 was 100% in cervical cancer. In CRC, prostate cancer, and breast cancer, it was 79%, 56%, and 25%, respectively.

    What Critical Areas of Cancer Care Still Need to Be Addressed With Additional Research?

    Regarding areas where progress is still needed, the report detailed that modifiable risk factors such as cigarette smoking, excess body weight, alcohol consumption, exposure to UV radiation, poor diet, pathogenic infections, and/or physical inactivity are attributable to 40% of all cancer cases in the United States and 41% of cases globally. The report also noted that from 2011 to 2019, 2,020,829 new cancer cases were diagnosed among individuals 15 to 49 years of age.

    The incidence of CRC increased 5.0% every year from 2018 to 2022 among individuals less than 50 years old compared with a 2.0% decrease per year among those who were at least 65 years old. From 2019 to 2023, the mortality rate increased 1.1% per year and decreased 2.3% per year in these respective groups.

    What Were the Findings From a Poll on Federal Funding for Cancer Research?

    During the report’s unveiling, presenters also displayed results from a survey of registered voters concerning their support for federal funding for cancer research. Findings from the survey indicated that 83% of respondents supported increased federal funding for cancer research, and 89% supported federal funding for all of medical research.

    Within the 83%, 42% strongly favored increased federal funding for cancer research, and 40% responded that they somewhat favored doing so. Notably, the preference for increasing funding was present in a majority of Democrat (93%), Republican (75%), and independent (75%) voters. Eighty-one percent of those who indicated that reducing debt/federal spending was a high priority also favored increasing funding for cancer research.

    Findings from the survey also revealed that the total confidence in cancer researchers and the National Cancer Institute was 71% and 65%, respectively. Forty-two percent and 35% of the respondents indicated that they had a great deal of confidence in these respective groups. Among voters who prioritized reducing debt/federal spending, 71% indicated that increasing funding for medical research to treat, prevent, and cure diseases, including cancer, was their highest or a high priority.

    “We’re grateful that leaders in both the House and the Senate Appropriations Committee are demonstrating strong bipartisan support for sustained federal funding for medical research,” Siu said. “The new poll conducted by the AACR shows 89% of voters support the federal government using taxpayer dollars to fund medical research, and we urge Congress to maintain this commitment to ensuring lifesaving discoveries continue. With continued investment, collaboration, and patient engagement, we can build on decades of progress and continue transforming cancer care for all our patients everywhere.”

    References

    1. AACR Cancer Progress Report 2025 release. September 17, 2025. Accessed September 17, 2025. https://www.workcast.com/Auditorium.aspx?cpak=4920217928247461&pak=1325993287995046
    2. AACR Cancer Progress Report 2025. September 17, 2025. Accessed September 17, 2025. https://cancerprogressreport.aacr.org/wp-content/uploads/sites/2/2025/09/AACR_CPR_2025.pdf

    Continue Reading

  • SpaceX moves next Starship spacecraft to launch pad for testing (photos)

    SpaceX moves next Starship spacecraft to launch pad for testing (photos)

    SpaceX has moved its newest Starship spacecraft to the launch pad for testing ahead of the megarocket’s upcoming 11th test flight.

    The company documented the milestone today (Sept. 17) via X, in a post that shared three photos of the shiny silver Starship upper stage.

    In one of those images, the 171-foot-tall (52-meter-tall) spacecraft — known as Starship, or just “Ship” — is rolling down a road at SpaceX’s Starbase site in South Texas at nighttime. In the other two, Ship is at the pad, nestled in the grasp of the launch tower’s “chopstick” arms.

    Ship on the move toward the pad at Starbase. (Image credit: SpaceX)

    The likely next steps are pressurization and engine tests, which will ensure Ship is ready to fly. The same prep work will also be done with Super Heavy, the huge booster that makes up the bottom half of the fully reusable, stainless-steel Starship.

    Continue Reading

  • Xbox ROG Ally: Retailer Leak Suggests Surprisingly Low Price Point

    Xbox ROG Ally: Retailer Leak Suggests Surprisingly Low Price Point

    It’s looking more likely that the Asus ROG Xbox Ally and Xbox Ally X handhelds will be priced at $549.99 and $899.99, thanks to former IGN staffer, Destin Legarie. In a YouTube video, Legarie claims to have confirmed the pricing with his local Best Buy, which “spilled the beans” when he called to ask. Just be sure to take this with a grain of salt.

    The console will also apparently get demo stations at Best Buy stores, according to Legarie, who provided images, provided by an anonymous source, of one of the stations from a Tennessee store. One image shows an RGB-laden kiosk with the ROG Xbox Ally X sitting in the middle on a clear plastic display stand. Behind it, a screen appears to be in the middle of a looping demo for the handheld and is flanked by promotions of its compatibility with all manner of Windows PC games. Another image shows a closeup of the $899.99 price tag.

    Xbox ROG Ally X demo station | Credit: Destin Legarie

    This is as close as we’ve gotten to confirmation of the Xbox version of Asus’ Ally handheld PC consoles, which are due for release on October 16, but until things are official, don’t go taking out that second mortgage or taking a third job to pay for the near-$900 Xbox Ally X just yet. It’s very possible it’s not true, for one thing. But even if it is, tarriffs could change matters more than they already have, including for handheld gaming PCs like the Legion Go 2, which will be as much as $1479. On the plus side, the rumored price for the vanilla Xbox Ally is $100 little cheaper than what retailers like Best Buy are asking for the non-Xbox version; hopefully, for anyone who wants to get in on this more user-friendly PC handheld without destroying the bank, that rumor holds.

    The price for the higher-end Xbox Ally X is likely to disappoint anyone who was already taken aback by the pricing for its Ryzen Z1 Extreme-powered predecessor. At the same time, despite keeping their launch prices of $799.99 on Asus’ website, retailers have already been selling the first-gen handhelds at higher prices, and if Legarie’s sources are correct, the entry-level Ally will be a better deal than the $649.99 Ally, with the non-Extreme Z1.

    Wes is a freelance writer (Freelance Wes, they call him) who has covered technology, gaming, and entertainment steadily since 2020 at Gizmodo, Tom’s Hardware, Hardcore Gamer, and most recently, The Verge. Inside of him there are two wolves: one that thinks it wouldn’t be so bad to start collecting game consoles again, and the other who also thinks this, but more strongly.

    Continue Reading

  • Ebola vaccination begins in southern Congo amid latest outbreak | The Transmission

    Ebola vaccination begins in southern Congo amid latest outbreak | The Transmission

    PBS Vaccination for those exposed to the Ebola virus and front-line health workers has begun in southern Kasai province, the World Health Organization said Sunday.

    An outbreak of the highly contagious disease was announced earlier this month in the locality of Bulape, in Kasai, and has left at least 16 dead and 68 suspected cases, according to last week’s briefing by the Africa Centers for Disease Control and Prevention. Only an initial 400 doses of the Ervebo vaccine have been dispatched, with the rest to be delivered later, the WHO said. The operation has been hampered by limited access and scarce funds.

    The vaccination is expected to pick up later as the International Coordinating Group on Vaccine Provision approved roughly 45,000 additional vaccines, the WHO said, adding to an initial stockpile of 2,000 doses was already in the country.

    Continue Reading

  • 3 police officers killed and 2 injured in rural Pennsylvania shooting

    3 police officers killed and 2 injured in rural Pennsylvania shooting

    NORTH CODORUS, Pa. (AP) — Three police officers were fatally shot and two wounded Wednesday in southern Pennsylvania, and the shooter was killed by police, authorities said.

    The officers were at the scene, amid rolling farmland, to follow up on a domestic-related investigation that began the previous day.

    “This is an absolutely tragic and devastating day,” Gov. Josh Shapiro said at a news conference. “We grieve the loss of life of three precious souls who served this county, who served this Commonwealth, who served this country.”

    “This kind of violence is not OK. We need to do better as a society,” Shapiro said.

    It was one of the deadliest days for Pennsylvania police this century. In 2009 three Pittsburgh officers responding to a domestic disturbance were ambushed and shot to death by a man in a bulletproof vest.

    Condolences began pouring in from police departments across the region on social media and people began leaving flowers at the headquarters of the Northern York Regional Police Department.

    “The grief will be unbearable but we will bear it,” said Pennsylvania State Police Commissioner Christopher Paris, who pledged a full, fair investigation.

    Dozens of police and emergency vehicles with their lights flashing formed a procession to the coroner’s office. People lined the road holding American flags and saluted as it passed.

    The shooting erupted in the area of North Codorus Township, about 115 miles (185 km) west of Philadelphia, not far from the Maryland line, authorities said.

    Dirk Anderson, a farmer who lives across a two-lane country road from the scene, said he was in his shop “when we heard shots,” which he described as “quite a few.” He saw a helicopter arrive and a large police vehicle response.

    The two injured officers were in critical but stable condition at York Hospital, authorities said.

    Authorities did not identify the shooter, the officers or which police department they belonged to, or describe the circumstances of how they were shot, citing the ongoing investigation.

    Shapiro said he and other officials met with the slain officers’ families, who, while grieving, took the time to say how proud they were of their loved ones.

    Attorney General Pamela Bondi called the violence against police “a scourge on our society.” She said federal agents were on the scene to support local officers.

    The emergency response unfolded on a rural road in south-central Pennsylvania. Officers were keeping people well back from the scene, with some 30 police vehicles blocking off roads bordered by a barn, a goat farm and soybean and corn fields.

    Another officer in the area was killed in February, when a man armed with a pistol and zip ties entered a hospital’s intensive care unit and took staff members hostage before a shootout that left both the suspect and an officer dead.

    “We need to do better as a society,” Shapiro said. “We need to help the people who think that picking up a gun, picking up a weapon is the answer to resolving disputes. We need do better when it comes to mental health.

    “We need to do better when it comes to looking out for those who are in need so we don’t have to deal with tragedies like this,” he said.

    ___

    Associated Press reporters Patrick Whittle in Portland, Maine; Kimberlee Kruesi in Providence, Rhode Island and Michael Casey in Boston, contributed to this report. Levy reported from Harrisburg, Pennsylvania and Dale from Philadelphia.

    Continue Reading

  • Not Getting Much Out of Apple Intelligence? Here’s How to Turn It Off on iPhone, iPad and Mac

    Not Getting Much Out of Apple Intelligence? Here’s How to Turn It Off on iPhone, iPad and Mac

    Apple Intelligence did not feature prominently in the release of the new iOS 26 and MacOS Tahoe, but it’s still a core feature of Apple’s product lineup. I’ve found several features to be helpful on a daily basis, but I acknowledge that the company’s AI efforts can feel limited or intrusive. The good news is that it’s easy to turn Apple Intelligence off entirely or selectively switch off individual features.

    See also: Did a well-meaning friend send you a message about Apple Intelligence possibly reading your private information? I explain what’s actually going on.

    Don’t miss any of our unbiased tech content and lab-based reviews. Add CNET as a preferred Google source.

    Why turn off Apple Intelligence in the first place?

    Since the first Apple Intelligence features rolled out last year in iOS 18.1, some people have opted out of the new technology. Tools such as Image Playground, Genmoji and message summaries can use up to 7GB of your device’s internal storage — a sizable chunk, especially if you tend to run against the upper limit of its free space.

    Even if storage is not an issue, you just may not be interested in Apple’s set of AI features. A new CNET survey finds that just 19% of US smartphone owners are choosing to upgrade their devices to take advantage of new AI features. And a recent ZDNET/Aberdeen survey reveals that the majority of US adults say they will not use most AI features, and just 8% would consider paying extra for them. Some AI features are more welcome than others, with 58% of respondents saying using AI for photo editing would be valuable.

    Or, honestly, you may not want to deal with features that are creating inaccurate summaries or that can be replicated without Apple Intelligence.

    notification summary for a text message

    The trainer killed someone?

    Screenshot by Nelson Aguilar/CNET

    (Earlier iOS 18 updates re-enabled Apple Intelligence automatically even if you had turned it off, but as of iOS 18.4, the setting is honored.)

    Is Apple Intelligence really ready to be on by default?

    I’m not an AI crank — I appreciate features such as notification summaries and the Clean Up tool in the Photos app. And yet, Apple Intelligence is also a work in progress, an evolving set of features that Apple is heavily hyping while gradually developing. I wouldn’t hold it against you if you wanted to not be distracted or feel like you’re doing Apple’s testing for them (that’s what the developer and public betas are for).

    Remember that Apple Intelligence works only on the iPhone 17, iPhone 17 Pro, iPhone Air, iPhone 16, iPhone 16E, iPhone 16 Pro, iPhone 15 Pro, or M-series Macs and iPads, plus the newest iPad mini.

    Watch this: Does Apple Think We’re Stupid? Apple Intelligence Ads Say Yes

    How to see the amount of storage Apple Intelligence is using

    If you’re concerned about the storage requirements of Apple Intelligence, you can find out how much the system is using by going to Settings > General > iPhone (or iPad) Storage > iOS (or iPadOS).

    Two iPhone screenshots of the Settings panel showing iOS storage and Apple Intelligence portion of that.

    See how much space Apple Intelligence is using in Settings.

    Screenshots by Jeff Carlson/CNET

    Note that even after turning off Apple Intelligence, that storage still shows up in the iOS Storage list. However, I was able to confirm that if the phone’s storage fills up and the system needs that now-inactive space, iOS reclaims what it needs.

    Two iPhone screenshots of the Settings panel showing iOS storage and Apple Intelligence portion of that.

    Once I filled my iPhone’s storage, the inactive Apple Intelligence data was purged to accommodate the added files, dropping from 5.89GB to 2.87GB.

    Screenshots by Jeff Carlson/CNET

    How to turn off Apple Intelligence entirely (iPhone, iPad and Mac)

    Open Settings (iPhone or iPad) or System Settings (Mac) and choose Apple Intelligence & Siri. Then turn off the Apple Intelligence option. Confirm your choice in the dialog that appears by tapping Turn Off Apple Intelligence.

    Two iPhone screenshots showing the Apple Intelligence & Siri settings. At left the Apple Intelligence option is highlighted. At right it's turned off with a confirmation dialog visible.

    Turn off Apple Intelligence entirely with one switch.

    Screenshots by Jeff Carlson/CNET

    Here’s what you lose:

    (Curiously, the Clean Up tool in Photos sticks around even when Apple Intelligence is turned off, perhaps because the first time you use it the app downloads resources for it and holds onto them.)

    How to turn off individual Apple Intelligence features

    Maybe you’re finding some Apple Intelligence features helpful while others are annoying (or just highly amusing). You can turn off specific features in the settings for apps to which they apply.

    For example, to disable text summaries in Messages notifications, go to Settings > Apps > Messages and switch off the Summarize Messages option.

    iPhone setting screenshot turning off the Summarize Messages option in the Messages.

    Turn off Messages summaries while still using other Apple Intelligence features.

    Screenshot by Jeff Carlson/CNET

    Some features are not as app-specific. Writing Tools, which use Apple Intelligence to proof or rewrite text, appear as an option when you select text, regardless of the app. To turn that off, you need to disable Apple Intelligence system-wide.

    Also note that nearly every app includes an Apple Intelligence & Siri option in Settings, with a Learn from this App option (turned on by default). That applies just to whether Apple Intelligence and Siri can monitor how you use it to make suggestions; it doesn’t affect any particular Apple Intelligence features. (Did someone forward you a social media post saying that Apple Intelligence is stealing your private data? That’s not what’s happening.)

    How to turn off Apple Intelligence features in Screen Time settings

    Another option for restricting what Apple Intelligence can do is buried in the Screen Time settings. Screen Time is designed to control which apps and features can run on another device, such as the iPhone used by a child in your household. But it’s also helpful for tracking how much time you’re spending on the device and, in this case, turning off some components of Apple Intelligence.

    1. Open the Settings app and go to Screen Time > Content & Privacy Restrictions.
    2. Turn on the Content & Privacy Restrictions option if it’s not already enabled. If this is the first time you’re flipping this switch, don’t worry — everything is allowed by default.
    3. Tap Intelligence & Siri.
    4. Tap on the following three features and decide whether to allow or don’t allow their use: Image Creation (such as Image Playground and Genmoji), Writing Tools and the ChatGPT Extension (which uses ChatGPT to process requests that are beyond the built-in Apple Intelligence capabilities).

    iOS 18 Screen Time settings for turning off Apple Intelligence features.

    Turn off selected Apple Intelligence features in the Screen Time settings.

    Screenshots by Jeff Carlson/CNET

    For more on changes in iOS 18, see how the Mail app sorts messages into categories and if you haven’t upgraded already, make a good backup first. And if you’re upgrading to the next version, iOS 26, be sure to check out the hidden features you should try right now.

    Your iPhone Wants These 11 Essential Accessories in the New Year

    See all photos


    Continue Reading

  • Dollar whipsawed as Fed delivers normal-sized rate cut – Reuters

    1. Dollar whipsawed as Fed delivers normal-sized rate cut  Reuters
    2. Stocks flat, dollar edges higher as investors await Fed rate decision  Reuters
    3. Dollar sinks to four-year low vs euro  Business Recorder
    4. Forex Today: It’s all about the Federal Reserve  FXStreet
    5. Dollar falls ahead of Fed meeting, retail sales; euro on the rise  Investing.com

    Continue Reading

  • Belly Conklin Stans, Rejoice: ‘The Summer I Turned Pretty’ Is Becoming a Movie

    Belly Conklin Stans, Rejoice: ‘The Summer I Turned Pretty’ Is Becoming a Movie

    This story contains spoilers for the Season 3 finale of The Summer I Turned Pretty.

    Just as I was drying my tears and rending my garments (okay, overstatement—but, like, barely) about the third season of The Summer I Turned Pretty coming to an end this week, good news appeared like manna from teen-drama heaven: Prime Video recently greenlit a feature film wrapping up the events of the Season 3 finale. So, even if we won’t be getting the fourth season that we all long for, the chance for fans of Lola Tung’s Belly Conklin (Bellissimas? Bell-erinas? Suggestions welcome!) to see her reliable boy drama play out on the big screen isn’t one to take for granted.

    We don’t know the plot details of The Summer I Turned Pretty’s movie—which I will henceforth be referring to as The Summer I Turned Movie—just yet, but we do know that Jenny Han, who wrote the books on which the wildly popular TV show was based, will be penning the script (thank God).

    “There is another big milestone left in Belly’s journey, and I thought only a movie could give it its proper due. I’m so grateful to Prime Video for continuing to support my vision for this story and for making it possible to share this final chapter with the fans,” Han said in a statement on Wednesday.

    Photo: Anthony Ghnassia

    Continue Reading